Evaluating a Mobile App for Long-Term Follow-up and Support in Patients with Atrial Fibrillation or Heart Failure

What this Trial Is About

Researchers are studying a new mobile application designed to support patients with atrial fibrillation AF and heart failure HF in managing their health from home. This app aims to actively involve patients in different aspects of their condition and treatment. The study will evaluate how usable the app is, how well patients stick with using it over time, and their satisfaction with the apps follow-up support. Participants will use the Cardio2U application during the follow-up period, which offers educational content about AF and HF, tools to save health appointments, track measurements like heart rate and blood pressure, maintain a medication list with reminders, and complete questionnaires about knowledge, self-care, quality of life, physical activity, and symptoms. The app is personalized to each patients clinical needs. App usage data and questionnaire responses will be collected at set intervals to assess usability, satisfaction, knowledge, and self-care abilities. Throughout the study, participants will provide information through questionnaires and their app activity will be monitored to understand usage patterns. Doctors and nurses will have access to clinical questionnaire results via a healthcare provider dashboard to help guide patient care. The study will measure changes in usability and satisfaction at 3 and 12 months, and adherence up to 36 months. The total participation time varies, with follow-up assessments occurring up to one year and adherence monitored longer-term.

Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)